AGRX Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 0.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Agile Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Agile Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$20k-$10k$0$10k$20kTotal Insider BuyingTotal Insider Selling

Agile Therapeutics Share Price & Price History

Current Price: $1.51
Price Change: +0.30 (1.20%)
As of 08/26/2024 01:00 AM ET

This chart shows the closing price history over time for AGRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Agile Therapeutics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Agile Therapeutics (NASDAQ:AGRX)

10.92% of Agile Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AGRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$0soldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20k$0$20kTotal InflowsTotal Outflows
Agile Therapeutics logo
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Read More on Agile Therapeutics

Today's Range

Now: $1.51
Low: $1.51
High: $1.52

50 Day Range

MA: $1.49
Low: $1.43
High: $1.51

52 Week Range

Now: $1.51
Low: $0.20
High: $2.63

Volume

120,938 shs

Average Volume

352,864 shs

Market Capitalization

$10.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58